Thumbay Labs, the largest network of CAP-accredited private diagnostic labs in the region owned by Thumbay Group, has launched COVID-19 testing under authorization by the Ministry of Health (MOH), UAE, augmenting the Coronavirus testing facilities of the country. Sample collection centers have been set up at all Thumbay Hospitals and Clinics located at Dubai, Sharjah, Umm Al Quwain, Ras Al Khaimah, Ajman and Fujairah. Timings are from 9am to 6pm.

To avail the testing facility, patients may walk in or book an appointment by calling the respective sample collection centers at the Thumbay hospitals and Thumbay clinics, or by contacting the Customer Care number of Thumbay Labs 04 6030555 or 05 66806455 (WhatsApp). People need to bring their valid Emirates ID to proceed with the test.

The UAE is among the leading countries of the world in terms of number of diagnostic tests conducted for Coronavirus detection. The WHO has already acknowledged the UAE’s status as the country with the most per capita testing numbers. We are happy that Thumbay Labs and Thumbay Hospitals are active participants in the UAE’s fight against the global pandemic.

‘’Humanity is facing unprecedented challenge from COVID-19 pandemic. In the war against novel Coronavirus, lab testing plays a very important role. We, at Thumbay Labs, are committed to lead from the front in this war. Thumbay Labs, known for speed and accuracy of reports, will strive tirelessly to provide quality COVID-19 lab testing for the UAE’s population,’’ said Dr. Nasir Parwaiz, Director, Thumbay Labs.

Thumbay Labs, accredited by the College of American Pathologists (CAP), is the first network of diagnostic labs in the region featuring Total Lab Automation. With ultramodern equipment’s & highly qualified professionals, Thumbay Labs offer more than 1500 routine and special tests, with a number of affordable health check panels for everyone. They also provide fast online reports.

Contact Center

Thumbay Labs: 04 6030555 / 05 66806455 (WhatsApp)

Send us your press releases to pressrelease.zawya@refinitiv.com 

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.